Own payer access and coverage strategy for national and regional commercial payers, PBMs, and IDNs.
Lead value-based discussions with medical and pharmacy directors to drive timely medical policy positions.
Navigate buy-and-bill, medical-benefit, and specialty-pharmacy access pathways for infused cell therapies.
Capricor Therapeutics is a biotechnology company advancing cell and exosome-based therapies for rare diseases, with a lead cell therapy for Duchenne muscular dystrophy. The company is a publicly traded, pre-commercial organization with a focus on scientific rigor, collaboration, and patient impact.
Establish clinical understanding and generate demand for products in targeted long-term care settings, including skilled nursing facilities and LTC pharmacies.
Develop strategic relationships with key decision makers such as prescribing HCPs, consultant pharmacists, and medical directors to educate on product value.
Manage and grow existing accounts while executing sales strategies to achieve targets and expand market access.
Shionogi is a pharmaceutical company focused on developing and delivering innovative medicines. As a global organization with a strong commitment to long-term care, they foster a culture of ethical standards and professional development.
Develop and execute a strategic territory business plan to support the launch of tirabrutinib for relapsed/refractory primary central nervous system lymphoma patients.
Build strong relationships with hematology/oncology healthcare professionals and key accounts to drive disease education and product readiness.
Communicate clinical data clearly, address barriers to treatment adoption, and collaborate cross-functionally to ensure seamless patient access.
Deciphera is a biopharmaceutical company focused on discovering, developing, and commercializing new medicines for cancer, neurologic and autoimmune disease. It is a member of Ono Pharmaceutical Co., Ltd., and offers a competitive compensation and benefits package including medical, dental, vision, and 401(k).
Build and lead a best-in-class specialty sales organization for CAR-T therapies in autoimmune diseases.
Develop go-to-market strategy, drive revenue growth, and ensure compliance with regulatory requirements.
Collaborate cross-functionally to optimize treatment center activation, patient access, and therapy adoption.
Kyverna Therapeutics is a patient-centered, clinical-stage biopharmaceutical company developing cell therapies for patients suffering from autoimmune diseases. Guided by core values, they are committed to transforming the future of treatment for autoimmune disease.